DERMAN PHARMA Co.
DERMAN PHARMA Co.
At Derman Pharma, we are committed to providing safe, high-quality pharmaceutical products to our customers in Iraq, Kurdistan, and beyond. We take the issue of counterfeit drugs and product integrity seriously, and we work closely with local ministries and regulatory bodies to ensure compliance with all relevant laws and regulations.
Counterfeit drugs are a serious problem in many parts of the world, including Iraq and Kurdistan. According to the World Health Organization, up to 10% of drugs sold worldwide may be counterfeit.
In Iraq, an estimated 30% of drugs sold on the market may be counterfeit or substandard. These products can pose serious risks to the health and safety of consumers, and we believe that it is our responsibility to take action to prevent their distribution.
Our Consumer Health Protection and Anti-Counterfeit Prevention Policy outlines our commitment to ensuring the safety and integrity of our products. We take a multi-faceted approach to this issue, including:
We are proud to be compliant with all relevant laws and regulations in Iraq, Kurdistan, and the European Union, including the Iraqi Drug Law, the Kurdistan Drug Law, and the European Union's Falsified Medicines Directive (FMD).
We believe that our commitment to consumer health protection and counterfeit prevention sets us apart from our competitors, and we are dedicated to maintaining the highest standards of product integrity and quality.
If you have any questions or concerns about our Consumer Health Protection and Anti-Counterfeit Prevention Policy, please do not hesitate to contact us.
We are committed to working with our partners and customers to ensure that everyone has access to safe and effective pharmaceutical products.
Copyright © 2019 - 2024 DERMAN PHARMA - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.